Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chao Liu, Zhi Mao, Mengmeng Yang, Hongjun Kang, Hui Liu, Liang Pan, Jie Hu, Jun Luo & Feihu Zhou. (2016) Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Therapeutics and Clinical Risk Management 12, pages 1455-1466.
Read now
Read now
John A. Bosso, Anthony M. Casapao, Jonathan Edwards, Kenneth Klinker, Christopher McCoy, David P. Nicolau, Katherine K. Perez, Andrew Marcarelli & Deeksha Dua. (2016) Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion. Hospital Practice 44:4, pages 183-189.
Read now
Read now
Articles from other publishers (22)
Kyle A. Weant & Haili Gregory. (2023) The Potential Utility of Single-Dose Long-Acting Intravenous Antibiotics for Acute Bacterial Skin and Skin-Structure Infections in the Emergency Department. Advanced Emergency Nursing Journal 45:3, pages 177-186.
Crossref
Crossref
Daniela Zinzi, Ioanna Vlachaki, Edel Falla, Theo Mantopoulos & Dilip Nathwani. (2022) Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective. The European Journal of Health Economics 23:8, pages 1371-1381.
Crossref
Crossref
Huijuan Li, Xueyan Liang, Guangyan Mo, Sitong Guo, Xiaoyu Chen & Yan Li. (2022) Efficacy and safety of optional parenteral antimicrobial therapy for complicated skin and soft tissue infections: A systematic review and Bayesian network meta-analysis. Medicine 101:34, pages e30120.
Crossref
Crossref
Joe Yang, Jaesh Naik, Matthew Massello, Lewis Ralph & Ryan James Dillon. (2022) Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms. Infectious Diseases and Therapy.
Crossref
Crossref
Ryan Dillon, Jennifer Uyei, Rajpal Singh & Eilish McCann. (2021) Antibacterial data synthesis challenges: a systematic review of treatments for complicated Gram-negative urinary tract infections. Journal of Comparative Effectiveness Research 10:18, pages 1385-1400.
Crossref
Crossref
Wissal Jame, Bilgen Basgut & Abdikarim Abdi. (2021) Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis. PLOS ONE 16:11, pages e0260539.
Crossref
Crossref
Saeed Bohlega, Ahmed Elboghdady, Awatef Al-Johani, Koshu Mahajan, Majdoline Khalil Mughari, Mai Al-Saqa’aby, Omneya Mohamed, Rola Alarieh & Yaser Al Malik. (2021) Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity–Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia. Value in Health Regional Issues 25, pages 189-195.
Crossref
Crossref
Laura Puzniak, Ryan Dillon, Thomas Palmer, Hannah Collings & Ashley Enstone. (2021) Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections. Infectious Diseases and Therapy 10:3, pages 1227-1252.
Crossref
Crossref
Huan Zhang, Weiying Zhou, Jin Wang & Yun Cai. (2021) Efficacy and safety of oritavancin for the treatment of acute bacterial skin and skin-structure infections: a systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 25, pages 380-389.
Crossref
Crossref
Therese M. DuaneJared M. HustonMorgan CollomAdam BeyerSara ParliSara BuckmanMark ShapiroAmy McDonaldJose DiazJeffrey M. TessierJames Sanders. (2021) Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections. Surgical Infections 22:4, pages 383-399.
Crossref
Crossref
Jack Zhang, John Conly, JoAnn McClure, Kaiyu Wu, Bjӧrn Petri, Duane Barber, Sameer Elsayed, Glen Armstrong & Kunyan Zhang. (2021) A Murine Skin Infection Model Capable of Differentiating the Dermatopathology of Community-Associated MRSA Strain USA300 from Other MRSA Strains. Microorganisms 9:2, pages 287.
Crossref
Crossref
Alec B. Walter, Jocelyn Simpson, J. Logan Jenkins, Eric P. Skaar & E. Duco Jansen. (2020) Optimization of optical parameters for improved photodynamic therapy of Staphylococcus aureus using endogenous coproporphyrin III. Photodiagnosis and Photodynamic Therapy 29, pages 101624.
Crossref
Crossref
Ying Zhang, Yan Wang, Mieke L. Van Driel, Treasure M. McGuire, Tao Zhang, Yuzhu Dong, Yang Liu, Leichao Liu, Ruifang Hao, Lu Cao, Jianfeng Xing & Yalin Dong. (2019) Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia. Antimicrobial Resistance & Infection Control 8:1.
Crossref
Crossref
Silvia Corcione, Tommaso Lupia & Francesco G. De Rosa. (2019) Skin and soft tissue infections after breast surgery. Current Opinion in Infectious Diseases 32:2, pages 87-94.
Crossref
Crossref
Jonathan A.T. Sandoe, Kordo Saeed, Achyut Guleri, Kieran S. Hand, Ryan Dillon, Mike Allen, Amazigom Mayes, Fiona Glen & Armando Gonzalez-Ruiz. (2019) Opportunities for antimicrobial stewardship in patients with acute bacterial skin and skin structure infections who are unsuitable for beta-lactam antibiotics: a multicenter prospective observational study. Therapeutic Advances in Infectious Disease 6, pages 204993611882365.
Crossref
Crossref
Claire Roger, Jason A. Roberts & Laurent Muller. (2017) Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones. Clinical Pharmacokinetics 57:5, pages 559-575.
Crossref
Crossref
Julian F. Guest, Jaime Esteban, Anton G. Manganelli, Andrea Novelli, Giuliano Rizzardini & Miquel Serra. (2017) Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis. PLOS ONE 12:11, pages e0187792.
Crossref
Crossref
Manjunath P. Pai. (2016) Anti-infective Dosing for Obese Adult Patients: A Focus on Newer Drugs to Treat Methicillin-resistant Staphylococcus aureus Acute Bacterial Skin and Skin Structure Infections. Clinical Therapeutics 38:9, pages 2032-2044.
Crossref
Crossref
Ivar S. Jensen, Elizabeth Wu, Weihong Fan, Thomas P. Lodise, David P. Nicolau, Scott Dufour, Philip L. Cyr & Katherine A. Sulham. (2016) Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis. Journal of Managed Care & Specialty Pharmacy 22:6, pages 752-764.
Crossref
Crossref
A. Russo, E. Concia, F. Cristini, F.G. De Rosa, S. Esposito, F. Menichetti, N. Petrosillo, M. Tumbarello, M. Venditti, P. Viale, C. Viscoli & M. Bassetti. (2016) Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clinical Microbiology and Infection 22, pages S27-S36.
Crossref
Crossref
Ivar S. Jensen, Thomas P. Lodise, Weihong Fan, Chining Wu, Philip L. Cyr, David P Nicolau, Scott DuFour & Katherine A. Sulham. (2015) Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis. Clinical Drug Investigation 36:2, pages 157-168.
Crossref
Crossref
Yahiya Y. Syed & Lesley J. Scott. (2015) Oritavancin: A Review in Acute Bacterial Skin and Skin Structure Infections. Drugs 75:16, pages 1891-1902.
Crossref
Crossref